Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood. 2003 Oct 01; 102(7):2379-86.